Table 2.
Investigation.
| Investigations | Variations | Nonsevere dengue (n = 84) | Severe dengue (n = 13) | Total (n = 97) | P value |
|---|---|---|---|---|---|
| TLC | Leukopenia (<4000 cells/mm3) | 22 (26.19%) | 3 (23.07%) | 25 (25.77%) | |
| Leukocytosis (>11000 cells/mm3) | 13 (15.47%) | 2 (15.38%) | 15 (15.46%) | ||
| Normal TLC (4000–11000/mm3) | 49 (58.33%) | 8 (61.53%) | 57 (58.7%) | ||
|
| |||||
| Liver enzymes | Rise in SGPT (IU/L) | ||||
| Total | 25 (29.76%) | 5 (38.46%) | 30 (30.92%) | 0.5326 | |
| 50–200 U | 23 | 1 | |||
| 200–1000 U | 2 | 1 | |||
| >1000 U | 0 | 3 | |||
| Rise in SGOT (IU/L) | |||||
| Total | 36 (42.85%) | 10 (76.92%) | 46 (47.42%) | 0.0346∗ | |
| 50–200 U | 31 | 1 | |||
| 200–1000 U | 5 | 4 | |||
| >1000 U | 0 | 5 | |||
|
| |||||
| TPC | >100001 | 66 (78.57%) | 4 (30.76%) | 70 (72.16%) | |
| 100000–50001 | 12 (14.28%) | 4 (30.76%) | 16 (16.49%) | ||
| <50000 | 6 (7.14%) | 5 (38.46%) | 11 (11.34%) | ||
|
| |||||
| Haematocrit | >36.3% | 27 (32.14%) | 6 (46.15%) | 33 (34.02%) | |
| <36.3% | 57 (67.85%) | 7 (53.84%) | 64 (65.97%) | ||
|
| |||||
| Chest X-ray | Pleural effusion | 17 (20.23%) | 8 (61.53%) | 25 (25.77%) | 0.0037∗ |
| Right sided effusion | 12 (14.28%) | 3 (23.07%) | 15 (15.46%) | 0.4179 | |
| Left sided effusion | 4 (4.76%) | 0 | 4 (4.12%) | ||
| Right + left effusion | 1 (1.19%) | 5 (38.46%) | 6 (6.18%) | 0.0001∗ | |
|
| |||||
| USG of abdomen | Hepatomegaly | 41 (48.80%) | 10 (76.92%) | 51 (52.57%) | |
| Ascites | 19 (22.61%) | 6 (46.15%) | 25 (25.77%) | ||
| Gall bladder wall edema | 0 | 2 (15.38%) | 2 (2.06%) | ||
|
| |||||
| Dengue serology | NS1 | 43 (51.19%) | 3 (23.07%) | 46 (47.42%) | |
| IgM | 30 (35.71%) | 2 (15.38%) | 32 (32.98%) | ||
| IgG | 3 (3.57%) | 0 | 3 (3.09%) | ||
| IgM & IgG | 5 (5.95%) | 6 (46.15%) | 11 (11.30%) | ||
| NS1 & IgM | 3 (3.57%) | 2 (15.38%) | 5 (5.14%) | ||
∗Significant P value.